Russia has started producing CoviVac, its third vaccine against COVID-19.
The new vaccine will soon be made available for use in its regions, though phase three trials are still under way, officials said on Thursday.
The most well-known Russian coronavirus vaccine is Sputnik V. Moscow has also given emergency approval to two shots, EpiVacCorona and CoviVac.
"The third Russian vaccine is entering civilian circulation and will appear in the regions in the coming days," the Science and Higher Education Ministry said in a statement.
The Chumakov Centre plans to produce up to 10 million doses of the vaccine a year, the ministry said.
Science Minister Valery Falkov said that phase three trials of the vaccine had begun, the Interfax news agency reported.
The Chumakov Centre's director said phase three trials would be completed within half a year, Interfax reported.
Scottish National Party (SNP) veteran John Swinney was elected as its new leader on Monday and is set to replace Humza Yousaf as Scotland's first minister after he emerged as the sole contender in the contest to pick a new premier.
Israel's military carried out airstrikes in Rafah on Monday, residents said, hours after Israel told Palestinians to evacuate parts of the southern Gaza city where more than a million people uprooted by the war have been sheltering.
Russia said on Monday it would practice the deployment of tactical nuclear weapons as part of a military exercise after what Moscow said were threats from France, Britain, and the United States.